ArticleCancer biomarkers : section A of Disease markers

In silico analysis suggests ELL2 as a survival-associated cross-tissue biomarker in gastric cancer.

Kiarash Zare et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.